Discover how rheumatoid arthritis advances through distinct stages, the symptoms at each phase, and treatment approaches that ...

Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...

JIA, formerly known as “Juvenile Rheumatoid Arthritis,” is an autoimmune disease of unknown cause. The arthritic condition affects an estimated 300,000 children in the United States and ...

A new Swedish study has, for the first time, shown a link between rheumatoid arthritis (RA) and cognitive decline in dementia patients. The study, published in the journal Neurology, emphasizes ...

With nearly 1.5 million people suffering from rheumatoid and juvenile arthritis in the United States, researchers at Shriners ...

With nearly 1.5 million people suffering from rheumatoid and juvenile arthritis in the United States, researchers at Shriners Children's St. Louis have discovered a revolutionary way to ...

A synthetic chronogenetic gene circuit for programmed circadian drug delivery - ...

FDA has authorized Hope Biosciences’ adipose-derived mesenchymal stem cells (HB-adMSCs) for use in the first pediatric ...